Paraneoplastic polyarthritis (PP) or carcinomatous polyarthritis is an inflammatory arthritis, is usually seronegative, and has a temporal and pathophysiological relationship with an underlying malignancy, which usually corresponds to solid tumors, and less frequently, to hematological neoplasms (1, 2). Although head and neck tumors may be a cause of PP (3, 4), its association with tongue carcinoma (TC) has not been reported. We present a case of PP as an initial manifestation of CL.
compatible with nonkeratinizing squamous cell carcinoma ( Figure 3 ). The patient was diagnosed with PP secondary to TC. The dose of oral prednisone was increased to 20 mg/day, without noticing changes. Subsequently, he received 2 cycles of local radiotherapy and 5 cycles of chemotherapy, with gradual resolution of polyarthritis within the month of initiation of antineoplastic treatment. The patient has not presented new episodes of arthritis during a 6-month follow-up period.
Written informed consent was obtained from the patient.
Discussion
Paraneoplastic syndrome (PS), including PP, is characterized by the following: 1) occurs during the course of a malignancy or precedes it, 2) symptoms do not arise from tumor invasion or compression, and 3) the clinical picture improves with the treatment of the underlying neoplasm (5) . Caldwell and McCallum identified the key features of PP, which include a close temporal relationship arthritis/neoplasia (12 months), advanced age, asymmetric joint involvement, sudden onset, predominance of lower extremities respecting hands and wrists, absence of RF, rheumatoid nodules and radiographic erosions, absence of a family history of rheumatic disease, and nonspecific synovial histopathology (6) , all of which were present in our case, except symmetry and hand involvement, which have also been described in some patients with PP (2). Its physiopathology is unknown, suggesting the participation of immunocomplexes and T lymphocytes with cross-reactivity against synovial antigens (1). PP responds poorly to treatment with nonsteroidal anti-inflammatory drugs, glucocorticoids, and disease-modifying antirheumatic drugs, generally achieving its resolution with the treatment of the underlying neoplasm, although tumor recurrence is not usually associated with reappearance of arthritis (1, 2) . PP has been reported as a manifestation of head and neck tumors, including laryngeal carcinoma (6), hypopharyngeal (4), and laryngopharyngeal (7), but not TC, and this neoplasm has been associated with other PSs, such as dermatomyositis, autoimmune retinopathy, subacute cerebellar degeneration, thrombophlebitis, and hypercalcemia (8-10). In our patient, the suspicion of PP led to the diagnosis of TC because it did not manifest direct symptoms of the tumor and was not accessible on physical examination; thus, it was detected in the complementary tests.
Conclusion
Head and neck tumors, including TC, may be a cause of PP and may be the initial manifestation in some cases. However, these neoplasms are not always evident on physical examination; hence, they must be considered, especially in patients with key characteristics of PP. 
